HTL Biotechnology vise une commercialisation dès 2029 d’un nouveau collagène recombinant

HTL is a biotechnology company, leading the way in the development and production of pharmaceutical-grade biopolymers designed to improve people’s lives. Source (opens in a new tab)

Website

https://htlbiotech.com/

Headquarters

FR